Question 1

What drugs are used to treat Ulcerative Colitis?

Accepted Answer

Our directory lists 41 drugs indicated for Ulcerative Colitis, including Rowasa, Mesalamine, Balsalazide Disodium, PHYTONADIONE. Each linked drug page has copay cards, patient assistance programs, and payer prior-authorization information where available. Always discuss treatment decisions with your prescribing clinician.

Question 2

Is there copay assistance for Ulcerative Colitis medications?

Accepted Answer

24 drugs on this page have an active manufacturer copay card and 22 have a patient assistance program. Copay cards typically reduce commercial-insurance out-of-pocket to $0-$10; PAPs cover uninsured or underinsured patients who meet income thresholds. Click any drug for direct application links.

Question 3

Are there travel grants or financial help for Ulcerative Colitis?

Accepted Answer

11 grants are listed for Ulcerative Colitis, 7 currently accepting applications. Grants may cover copays, premiums, travel to appointments, lodging, or living expenses. Eligibility typically depends on diagnosis, income, and insurance status.

Question 4

How do I use this Ulcerative Colitis page to save money on my prescriptions?

Accepted Answer

Start by clicking the specific drug your clinician prescribed. The drug page shows (1) manufacturer copay cards for commercially-insured patients, (2) patient assistance programs for uninsured / low-income patients, (3) prior authorization rules for Medicare Part D plans, and (4) independent pricing comparisons via Cost Plus Drugs, GoodRx, and NeedyMeds. For condition-specific help, check the grants listed on this page.

Payer	PA	Step therapy	Copay tier
— Medicare Part D	—	—	—
— Medicare Part D	—	—	—
— Medicare Part D	—	—	—
— Medicare Part D	—	—	—
— Medicare Part D	—	—	—
— Medicare Part D	—	—	—
— Medicare Part D	—	—	—
— Medicare Part D	—	—	—
— Medicare Part D	—	—	—
— Medicare Part D	Yes	—	—

Ulcerative Colitis

What help exists for Ulcerative Colitis

Drugs used to treat Ulcerative Colitis

Prior authorization patterns for Ulcerative Colitis drugs

Grants for Ulcerative Colitis patients